Weiwei Du
Impact in
- Ophthalmology top 10%
- Retinal Diseases and Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 3
- RNA Research and Splicing 2
- RNA modifications and cancer 2
- Ubiquitin and proteasome pathways 1
-
- Myasthenia Gravis and Thymoma 2
- Co-authors
- Yan Zhang (1 shared paper)Xiang Cheng (1 shared paper)Zhaoliang Chen (1 shared paper)Xiangdong He (3 shared papers)Wei He (3 shared papers)Xuean Mo (2 shared papers)Jinpin Li (2 shared papers)Jingli Liu (2 shared papers)
- Journals
- Oxidative Medicine and Cellular Longevity (2 papers)Oncology Reports (2 papers)Medicinal Chemistry Research (1 paper)Journal of Neuroimmunology (1 paper)Cell Cycle (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiwei Du
16 papers receiving 596 citations
Peers
Comparison fields: 5 of 80
- Ophthalmology 47
- Cancer Research 62
- Oncology 109
- Immunology 87
- Molecular Biology 239
Countries citing papers authored by Weiwei Du
This map shows the geographic impact of Weiwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Du more than expected).
Fields of papers citing papers by Weiwei Du
This network shows the impact of papers produced by Weiwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Du. The network helps show where Weiwei Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 223 | |
| 2 | 2018 | 121 | |
| 3 | 2024 | 40 | |
| 4 | 2020 | 33 | |
| 5 | 2017 | 33 | |
| 6 | 2017 | 30 | |
| 7 | 2016 | 28 | |
| 8 | 2016 | 23 | |
| 9 | 2018 | 18 | |
| 10 | 2017 | 17 | |
| 11 | 2019 | 13 | |
| 12 | A novel sphingosine kinase 1 inhibitor (SKI-5C) induces cell death of Wilms' tumor cells in vitro and in vivo. | 2016 | 11 |
| 13 | 2022 | 5 | |
| 14 | Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers. | 2023 | 3 |
| 15 | 2016 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2025 | 0 |
About Weiwei Du
Weiwei Du is a scholar working on Molecular Biology, Neurology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 600 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (2 papers), Myasthenia Gravis and Thymoma (2 papers), RNA Research and Splicing (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Allergic Rhinitis and Sensitization (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Ophthalmology (47 citations), Cancer Research (62 citations), Oncology (109 citations), Immunology (87 citations) and Molecular Biology (239 citations). Weiwei Du has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yan Zhang, Xiang Cheng, Zhaoliang Chen, Xiangdong He, Wei He, Xuean Mo, Jinpin Li, Jingli Liu, Yanfang Tao and Jian Pan. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Oncology Reports, Medicinal Chemistry Research, Journal of Neuroimmunology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.